Mimedx Group Share Price Today
(NASDAQ: MDXG)

Name: Mimedx Group Share Price Today (NASDAQ: MDXG) - Mimedx Group Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Mimedx Group share price is $6.32 & ₹534.83 as on 2 May 2025, 2.30 'hrs' IST

$6.32

▲

-0.56

(-8.14%)

Market is closed - opens 7 PM, 02 May 2025

View live Mimedx Group share price in Dollar and Rupees. Guide to invest in Mimedx Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mimedx Group, along with analyst recommendations, forecasts, and comprehensive financials.

Mimedx Group share price movements

Today's Low: $6.21
Today's High: $6.61
$6.32
1.74%
Downside
Day's Volatility :6.05%
Upside
4.39%
52 Weeks Low: $5.47
52 Weeks High: $10.14
$6.32
13.45%
Downside
52 Weeks Volatility :46.06%
Upside
37.67%

Mimedx Group (MDXG) Returns

Period	Mimedx Group, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-20.63%	-4.4%	0.0%
6 Months	-0.36%	-5.0%	0.0%
1 Year	-7.93%	-0.1%	0.0%
3 Years	68.83%	7.8%	-5.1%

Mimedx Group (MDXG) Key Statistics

in dollars & INR

Previous Close	$6.88
Open	$6.6
Today's High	$6.61
Today's Low	$6.21
Market Capitalization	$1.0B
Today's Volume	$704.4K
52 Week High	$10.14
52 Week Low	$5.47
Revenue TTM	$348.9M
EBITDA	$65.4M
Earnings Per Share (EPS)	$0.28
PE Ratio	24.39
Profit Margin	12.16%
Quarterly Earnings Growth YOY	-0.86%
Return On Equity TTM	25.01%

How to invest in Mimedx Group Stock (MDXG) from India?

It is very easy for Indian residents to invest directly in Mimedx Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mimedx Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mimedx Group or MDXG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mimedx Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mimedx Group shares which would translate to 0.134 fractional shares of Mimedx Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mimedx Group, in just a few clicks!

Returns in Mimedx Group (MDXG) for Indian investors in Rupees

The Mimedx Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Mimedx Group investment value today

Current value as on today

₹87,874

Returns

₹12,126

(-12.13%)

Returns from Mimedx Group Stock

₹13,543 (-13.54%)

Dollar Returns

₹1,417 (+1.42%)

Indian investors sentiment towards Mimedx Group (MDXG)

200%

Period: Apr 1, 2025 to May 1, 2025. Change in 30 Days versus previous period

Search interest for Mimedx Group Stock from India on INDmoney has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Mimedx Group

Essex Woodlands Health Ventures
19.13%
BlackRock Inc
6.51%
Trigran Investments Inc
5.17%
Vanguard Group Inc
4.55%
Paradigm Capital Management, Inc.
3.18%
Cannell Capital LLC
2.47%

Analyst Recommendation on Mimedx Group

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Mimedx Group(by analysts ranked 0 to 5 stars)

Analyst Forecast on Mimedx Group Stock (MDXG)

What analysts predicted

Upside of 105.7%

Target:

$13.00

Current:

$6.32

Insights on Mimedx Group Stock (Ticker Symbol: MDXG)

Price Movement
In the last 3 years, MDXG stock has moved up by 74.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 92.90M → 88.20M (in $), with an average decrease of 5.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 17.62M → 7.02M (in $), with an average decrease of 22.6% per quarter
MDXG vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 81.1%
MDXG vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 97.3% return, outperforming this stock by 22.5%
Price to Sales
ForMDXG every $1 of sales, investors are willing to pay $2.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Mimedx Group Technicals Summary

Sell

Neutral

Buy

Mimedx Group is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mimedx Group (MDXG) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mimedx Group, Inc.	-10.21%	-0.36%	-7.93%	68.83%	-4.5%
Biontech Se	11.56%	-6.61%	12.87%	-30.24%	127.41%
Regeneron Pharmaceuticals, Inc.	-4.3%	-29.03%	-36.14%	-9.35%	10.5%
Vertex Pharmaceuticals Incorporated	5.32%	8.08%	27.25%	89.22%	92.38%
Alnylam Pharmaceuticals, Inc.	-1.34%	-3.89%	75.14%	84.24%	92.68%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mimedx Group, Inc.	24.39	24.39	2.97	0.27	0.25	0.15	NA	1.31
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.38	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mimedx Group, Inc.	Buy	$1.0B	-4.5%	24.39	12.16%
Biontech Se	Buy	$29.5B	127.41%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	10.5%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$129.4B	92.38%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.3B	92.68%	NA	-12.37%

About Mimedx Group

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Organization	Mimedx Group
Employees	837
CEO	Mr. Joseph H. Capper
Industry	Biotechnology

Management People of Mimedx Group

Name	Title
Mr. Joseph H. Capper	CEO & Director
Mr. Douglas C. Rice CPA	Chief Financial Officer
Mr. William F. Hulse IV	General Counsel & Chief Administrative Officer
Mr. Scott M. Turner	Senior Vice President of Operations & Procurement
Mr. Matthew M. Notarianni	Head of Investor Relations
Mr. Mark P. Graves	Senior VP & Chief Compliance Officer
Ms. Hilary Dixon	Vice President of Investor Relations & Corporate Strategic Communications
Ms. Kate Surdez	Chief Human Resources Officer
Dr. David H. Mason Jr.	Chief Medical Officer
Dr. Robert Benjamin Stein M.D., Ph.D.	President of Regenerative Medicine & Biologics Innovation

Important FAQs about investing in MDXG Stock from India :

What is Mimedx Group share price today?

Mimedx Group share price today stands at $6.32, Open: $6.60 ; Previous Close: $6.88 ; High: $6.61 ; Low: $6.21 ; 52 Week High: $10.14 ; 52 Week Low: $5.47.

The stock opens at $6.60, after a previous close of $6.88. The stock reached a daily high of $6.61 and a low of $6.21, with a 52-week high of $10.14 and a 52-week low of $5.47.

Can Indians buy Mimedx Group shares?

Yes, Indians can invest in the Mimedx Group (MDXG) from India.

With INDmoney, you can buy Mimedx Group at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Mimedx Group at zero transaction cost.

How can I buy Mimedx Group shares from India?

It is very easy to buy Mimedx Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mimedx Group (MDXG) be purchased?

Yes, you can buy fractional shares of Mimedx Group with INDmoney app.

What are the documents required to start investing in Mimedx Group stocks?

To start investing in Mimedx Group, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.